DDX43 is also overexpressed in more than 50% of chronic myeloid leukemia (CML) cases, 20% of acute myeloid leukemia (29) cases, and more than 40% of multiple myeloma cases. This evidence concerns the gene DDX43 and chronic myelogenous leukemia, BCR-ABL1 positive.